tbuckley/cabot-search huggingface dataset:
POS0621 FOREFEET INFLAMMATION IN RECENT-ONSET ACPA-POSITIVE AND ACPA-NEGATIVE RA: CLINICALLY SIMILAR, BUT DIFFERENT IN UNDERLYING INFLAMED TISSUES
Authors: D. A. Ton, B. T. Van Dijk, H. W. Van Steenbergen, A. H. M. Van der Helm – Van Mil
Journal: Annals of the Rheumatic Diseases (2024)
POS0619 COMPARATIVE EFFECTS OF BIOLOGICAL AND TARGETED SYNTHETIC DMARDS ON INCIDENT CHRONIC KIDNEY DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ANSWER COHORT STUDY
Authors: N. Nishimura, A. Onishi, W. Yamamoto, K. Nagai, H. Shiba, Y. Okita, Y. Son, H. Amuro, T. Okano, Y. Ueda, R. Hara, M. Katayama, S. Yamada, M. Hashimoto, Y. Maeda, H. Onizawa, T. Fujii, K. Murata, K. Murakami, M. Tanaka, S. Matsuda, A. Morinobu
Journal: Annals of the Rheumatic Diseases (2024)
POS0488 ORAL HEALTH, ORAL FOLLOW-UP AND INFECTIOUS RISK MANAGEMENT OF RHEUMATOID ARTHRITIS PATIENTS ON ANTI-TNF DRUGS: A SURVEY OF A FRENCH E-COHORT
Authors: M. Gosset, L. Radoi, H. Marotte, M. Soubrier, S. Tropé, N. Hamamouche, R. Seror
Journal: Annals of the Rheumatic Diseases (2024)
POS0959 IMPACT OF INITIATION OF TARGETED THERAPY ON THE USE OF ASSOCIATED TREATMENTS AND HEALTHCARE CONSUMPTION IN PSORIATIC ARTHRITIS: A COHORT STUDY OF 9,793 PATIENTS FROM THE FRENCH HEALTH INSURANCE DATABASE (SNDS)
Authors: L. Pina Vegas, S. Iggui, E. Sbidian, P. Claudepierre
Journal: Annals of the Rheumatic Diseases (2024)
POS0881 INFLAMMATORY RHEUMATISMS UPON TARGETED THERAPIES FOR ASTHMA, THE RITA STUDY
Authors: A. Gandiolle, C. Taille, G. Devouassoux, E. Sebbag, N. Khayath, W. Claudine, J. Terrier, B. Mahrous, B. De Maleprade, M. Forien, C. Salliot, J. Sibilia, J. E. Gottenberg, A. Meyer
Journal: Annals of the Rheumatic Diseases (2024)
POS0489 COMPARISON OF THE EFFECTS OF BARICITINIB AND ABATACEPT ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A PROPENSITY SCORE MATCHING ANALYSIS
Authors: S. Asai, N. Takahashi, K. Terabe, Y. Yoshioka, T. Kojima, T. Kobayakawa, Y. Sobue, T. Watanabe, Y. Hirano, Y. Kanayama, T. Kato, M. Hanabayashi, M. Suzuki, S. Imagama
Journal: Annals of the Rheumatic Diseases (2024)
POS1030 IS RHEUMATOID ARTHRITIS ALWAYS PRECEDED BY A SYMPTOMATIC PHASE OF CLINICALLY SUSPECT ARTHRALGIA?
Authors: S. Claassen, A. M. P. Boeren, S. J. H. Khidir, H. W. Van Steenbergen, A. H. M. Van der Helm – van Mil
Journal: Annals of the Rheumatic Diseases (2024)
POS1224 CHARACTERISATION OF SIGNALLING LYMPHOCYTIC ACTIVATION MOLECULES (SLAM) IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
Authors: K. Lowe, J. Kasparian, A. Small, H. Weedon, E. Masle-Farquhar, M. Singh, S. M. Proudman, M. D. Smith, M. Wechalekar
Journal: Annals of the Rheumatic Diseases (2024)
AB0270 CHARACTERISTICS OF IDIOPATHIC INFLAMMATORY MYOPATHY PATIENTS WITH INTERSTITIAL LUNG DISEASE: RESULTS OF A SINGLE-CENTER FROM TURKEY
Authors: A. Ilbay, E. Uslu Yurteri, N. Göveç Giynaş, M. E. Yayla, D. Sahin Eroglu, A. Gaydan, A. Usta, Y. Mahmutoğlu, Z. Karaman Ongun, Ç. Ergül, Ö. Özdemir Kumbasar, T. M. Turgay, A. Ates
Journal: Annals of the Rheumatic Diseases (2024)
Neurobiology and Treatment of Posttraumatic Stress Disorder
Authors: Arieh Shalev, Dayeon Cho, Charles R. Marmar
Journal: American Journal of Psychiatry (2024)

The recent worldwide surge of warfare and hostilities exposes increasingly large numbers of individuals to traumatic events, placing them at risk of developing posttraumatic stress disorder (PTSD) and challenging both clinicians and service delivery systems. This overview summarizes and updates the core knowledge of the genetic, molecular, and neural circuit features of the neurobiology of PTSD and advances in evidence-based psychotherapy, pharmacotherapy, neuromodulation, and digital treatments. While the complexity of the neurobiology and the biological and clinical heterogeneity of PTSD have challenged clinicians and researchers, there is an emerging consensus concerning the underlying mechanisms and approaches to diagnosis, treatment, and prevention of PTSD. This update addresses PTSD diagnosis, prevalence, course, risk factors, neurobiological mechanisms, current standard of care, and innovations in next-generation treatment and prevention strategies. It provides a comprehensive summary and concludes with areas of research for integrating advances in the neurobiology of the disorder with novel treatment and prevention targets.
AB0361 SNP OF ANGIOTENSIN CONVERTING ENZYME GENE (rs4343) ASSOCIATION WITH SUSCEPTIBILITY TO KNEE OSTEOARTHRITIS AND INCREASED SERUM ANGIOTENSIN II LEVEL
Authors: H. Elzomor, B. Elnaggar, N. Elbaky, E. Albeltagy, A. Khater, N. Mosellhy, H. Elzomor
Journal: Annals of the Rheumatic Diseases (2024)
AB0451 COMPARING THE 2023 PREVENTTM AND THE 2013 AMERICAN COLLEGE OF CARDIOLOGY/AMERICAN HEART ASSOCIATION ALGORITHMS FOR DETECTION OF CAROTID PLAQUE IN PSORIATIC ARTHRITIS PATIENTS
Authors: N. Guajardo-Jauregui, J. R. Azpiri-Lopez, I. J. Colunga-Pedraza, D. A. Galarza-Delgado, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, V. González-González, A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez
Journal: Annals of the Rheumatic Diseases (2024)
POS0618 NAVIGATING RHEUMATIC SARCOPENIA: OVERCOMING D2T-RA AND DEALING WITH THE MULTIFACETED NATURE OF FRAILTY
Authors: Y. Ohashi, N. Takahashi, M. Suzuki, Y. Sobue, K. Terabe, S. Asai, S. Imagama
Journal: Annals of the Rheumatic Diseases (2024)
POS1221 PROTEIN QUANTITATIVE TRAIT LOCI IDENTIFIES GENETIC BIOMARKERS OF PROTEINS ASSOCIATED WITH MEASURES OF MYOCARDIAL FIBROSIS IN NEW-ONSET, TREATMENT NAÏVE RHEUMATOID ARTHRITIS
Authors: A. I. Mohammed, R. R. Shukla, C. F. Yap, S. Plein, D. Plant, M. Buch
Journal: Annals of the Rheumatic Diseases (2024)
POS0974 MULTISPECTRAL OPTOACOUSTIC TOMOGRAPHY OF THE ENTHESES REVEALS COMMON METABOLIC PROFILES IN PSORIASIS AND PSORIATIC ARTHRITIS: RESULTS FROM THE MAPSA STUDY
Authors: F. Fagni, K. Tascilar, R. N. De Sousa, S. Bayat, L. Sollfrank, A. Kleyer, M. Sticherling, A. Regensburger, F. Knieling, M. F. Neurath, G. Schett, M. Waldner, D. Simon
Journal: Annals of the Rheumatic Diseases (2024)
AB0504 DRIVERS OF DISCORDANCE BETWEEN THE PATIENT-REPORTED RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX (RADAI) AND THE SIMPLIFIED DISEASE ACTIVITY INDEX (SDAI) CONCERNING THE ACHIEVEMENT OF TREAT-TO-TARGET GOALS – DATA FROM THE REAL STUDY
Authors: V. Cruz, C. Albuquerque, A. P. Gomides, R. D. Neubarth Giorgi, L. Pereira, S. Radominski, I. Pereira, M. F. B. De Resende Guimarães, M. Bertolo, P. Louzada, M. D. F. Sauma, K. Bonfiglioli, C. Brenol, L. Mota, G. Castelar-Pinheiro
Journal: Annals of the Rheumatic Diseases (2024)
POS1226 REDUCED EXPRESSION OF GPR55 ON B-CELLS IN EARLY RHEUMATOID ARTHRITIS PATIENTS: A CANDIDATE MODULATOR OF IMMUNE RESPONSES IN ATHEROSCLEROSIS
Authors: D. Miranda-Prieto, M. Alperi-López, J. Rodríguez-Carrio, Á. I. Pérez-Álvarez, S. Alonso-Castro, A. Suárez
Journal: Annals of the Rheumatic Diseases (2024)
POS1225 KREBS VON DEN LUNGEN-6 PROTEIN AS A KEY SERUM BIOMARKER FOR THE EARLY AND ACCURATE DIAGNOSIS OF RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE
Authors: V. Pulito-Cueto, B. Atienza-Mateo, J. G. Ocejo-Vinyals, V. M. Mora-Cuesta, D. Iturbe Fernández, J. Batista-Liz, M. Sebastián Mora-Gil, A. Triguero-Martinez, P. Quiroga Colina, E. Vicente-Rabaneda, S. Castañeda, J. M. Cifrián-Martínez, R. Blanco, R. López-Mejías
Journal: Annals of the Rheumatic Diseases (2024)
AB0323 IS GOUT ASSOCIATED WITH AN EXCESS FRACTURE RISK?
Authors: Y. Makhlouf, W. Tekaya, S. Miladi, A. Fazaa, H. Boussaa, L. Souabni, K. Ouenniche, S. Kassab, S. Chekili, K. Ben Abdelghani, A. Laatar
Journal: Annals of the Rheumatic Diseases (2024)
POS1068 UNVEILING INFLAMMATION: RADIOLOGICAL SURPRISES IN DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS (DISH)
Authors: R. Ben Chehida, R. Fakhfakh, D. Khalifa, C. Daldoul, N. El Amri, H. Hachfi, K. Baccouche, E. Bouajina
Journal: Annals of the Rheumatic Diseases (2024)
AB0388 JANUS KINASE INHIBITORS IN UVEITIS DUE TO IMMUNE-MEDIATED INFLAMMATORY DISEASES. MULTICENTER STUDY AND LITERATURE REVIEW
Authors: L. Sanchez-Bilbao, J. L. Martín-Varillas, V. Calvo-Río, M. D. M. Esteban-Ortega, S. Munoz-Fernández, J. L. Álvarez-Vega, E. Beltrán, V. Jovani, O. Maiz-Alonso, R. Veroz González, C. Álvarez-Reguera, R. Demetrio-Pablo, R. Blanco
Journal: Annals of the Rheumatic Diseases (2024)
OP0127 PREDICTING PERSISTENT INFLAMMATORY ARTHRITIS IN PATIENTS WITH PALINDROMIC RHEUMATISM: DEVELOPMENT OF SCORES FOR RISK STRATIFICATION
Authors: R. Chowdhury, F. Shuweihdi, N. Sidhu, L. Duquenne, L. Garcia-Montoya, J. Nam, A. DI Matteo, K. Harnden, D. Sahin Eroglu, P. Emery, K. Mankia
Journal: Annals of the Rheumatic Diseases (2024)
POS0989 REAL-WORLD BURDEN OF UNCONTROLLED DISEASE DESPITE TREATMENT WITH TUMOR NECROSIS FACTOR INHIBITORS AMONG PSORIATIC ARTHRITIS PATIENTS IN THE COREVITAS PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS REGISTRY
Authors: P. J. Mease, X. Ye, C. D. Saffore, B. Parikh, S. Ciecinski, T. Blachley, M. Eliot, N. Middaugh, A. Ogdie
Journal: Annals of the Rheumatic Diseases (2024)
POS0454 JANUS-KINASE-INHIBITORS (JAKi) SIGNIFICANTLY IMPAIR SIGNAL-TRANSDUCER-AND-ACTIVATOR-OF-TRANSCRIPTION (STAT) SIGNALING OF VARICELLA-ZOSTER-VIRUS-(VZV)-SPECIFIC T-CELL MEMORY RESPONSES
Authors: G. Almanzar, F. Baum, M. Steimer, L. Jahn, S. Hick, A. Ess, C. Rack, I. Turin, A. Schäfer, P. Arampatzi, T. Bischler, T. Gräfenhan, F. Erhard, T. Hennig, L. Doelken, M. Feuchtenberger, M. Schmalzing, M. Prelog
Journal: Annals of the Rheumatic Diseases (2024)
AB0477 EXPERIENCES AND PERSPECTIVES OF PATIENTS WITH PSORIATIC ARTHRITIS PARTICIPATING IN A RANDOMIZED CONTROLLED TRIAL OF DIETARY INTERVENTIONS
Authors: L. Eder, S. Tarannum, K. Bush, S. Cohen, C. Compher, H. Emandoilidis, D. D. Gladman, V. Chandran, J. U. Scher, A. Ogdie
Journal: Annals of the Rheumatic Diseases (2024)
AB0425 APPLICATION OF A PREDICTION MODEL TO IDENTIFY PSORIATIC ARTHRITIS PATIENTS WITH A HIGHER DIFFICULTNESS-TO-TREAT – ANALYSIS FROM A SINGLE-CENTRE COHORT
Authors: M. Ferrito, G. Cincinelli, M. Pandolfi, M. Biggioggero, S. Casari, M. Manara, M. Cornalba, C. Crotti, F. Desiati, G. Biganzoli, E. Luconi, P. Boracchi, R. F. Caporali, E. G. Favalli
Journal: Annals of the Rheumatic Diseases (2024)
AB0321 PARTICULARITIES AND PREVALENCE OF VERTEBRAL FRACTURES IN PATIENTS WITH DIFFUSE INTERSTITIAL LUNG DISEASE
Authors: A. Saad, K. Baccouche, R. Fakhfakh, D. Khalifa, C. Daldoul, H. Hachfi, N. El Amri, E. Bouajina
Journal: Annals of the Rheumatic Diseases (2024)
AB0493 DISCERNING THE MOST EFFECTIVE PREDICTOR OF CARDIOVASCULAR RISK FOR PATIENTS WITH PSORIATIC ARTHRITIS
Authors: V. Gonzalez-Gonzalez, I. J. Colunga-Pedraza, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, N. Guajardo-Jauregui, A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez
Journal: Annals of the Rheumatic Diseases (2024)
POS1220 MODULATING INFLAMMATION IN AN ADVANCED 3D MODEL OF RHEUMATOID ARTHRITIS SYNOVIAL TISSUE INCORPORATING FIBROBLASTS, ENDOTHELIAL CELLS AND MACROPHAGES
Authors: E. Philippon, J. P. Van Hamburg, L. Van Rooijen, G. P. Sims, C. J. Van der Laken, S. W. Tas
Journal: Annals of the Rheumatic Diseases (2024)
AB0405 IMPACT OF THE HLA-Cw6*0602 ALLELE AND IFIH1/MDA5 GENE VARIANTS ON CARDIOMETABOLIC RISK FACTORS IN PATIENTS WITH PSORIATIC DISEASE
Authors: R. Queiro, I. Braña Abascal, M. Loredo Martinez, E. Pardo Campo, S. Burger, P. González del Pozo, P. Alvarez, S. Alonso-Castro, E. Fernández-Bretón, M. Alperi-López
Journal: Annals of the Rheumatic Diseases (2024)
AB0494 ROLE OF HEMATOLOGICAL INDICES IN PATIENTS WITH PSORIATIC ARTHRITIS
Authors: I. Vázquez-Gómez, L. Montolio-Chiva, J. Lacasa-Molina, L. Perea-Galera, A. Taberner-Cortés, M. Robustillo-Villarino, À. Martínez-Ferrer, E. Valls-Pascual, D. Ybáñez-García, C. Valera-Ribera, P. Andújar-Brazal, A. Mayo-Juanatey, P. León-Torralba, J. J. Alegre-Sancho
Journal: Annals of the Rheumatic Diseases (2024)
POS0973 DECODING THE COMPLEXITY OF REFRACTORY PSORIATIC ARTHRITIS: RESULTS FROM A GLOBAL HEALTHCARE SURVEY INFORMED BY GRAPPA SPECIALISTS’ EXPERTISE
Authors: A. Ribeiro, S. Singla, V. Chandran, N. Chronis, W. Liao, C. Lindsay, E. R. Soriano, P. J. Mease, F. Proft
Journal: Annals of the Rheumatic Diseases (2024)
AB0474 LATE ONSET VS. EARELY ONSET PSORIATIC ARTHRITIS: IS THERE DIFFERENCES? DATA FROM AN ALGERIAN OBSERVATIONAL STUDY
Authors: A. Djebbari, G. Aissa, A. Abdelatif, B. Samir, O. Sonia, B. Abdelatif
Journal: Annals of the Rheumatic Diseases (2024)
AB0406 DEVELOPMENT AND VALIDATION OF A QUESTIONNAIRE FROM A PATIENT PERSPECTIVE TO ASSESS CHALLENGES IN PSORIATIC ARTHRITIS TREATMENT – A QUALITATIVE STUDY
Authors: A. Ribeiro, J. Andressa Tessari, C. Kohem, P. Esther Palominos, R. Mendonça Da Silva Chakr
Journal: Annals of the Rheumatic Diseases (2024)
OP0107 NATIONWIDE EPIDEMIOLOGY OF FRACTURE INCIDENCE IN PATIENTS TREATED WITH DENOSUMAB: DATA ON 271 295 PATIENTS FROM THE FRENCH HEALTHCARE INFORMATION SYSTEM
Authors: D. Laurent, C. Yamdjieu-Ngadeu, R. M. Javier, E. Sauleau, J. Sibilia, C. Confavreux, J. E. Gottenberg, E. Sebbag
Journal: Annals of the Rheumatic Diseases (2024)
OP0059 VOCLOSPORIN-BASED, TRIPLE-IMMUNOSUPPRESSIVE REGIMEN VERSUS HIGH-DOSE GLUCOCORTICOID AND MYCOPHENOLATE MOFETIL-BASED THERAPY FOR LUPUS NEPHRITIS: A PROPENSITY ANALYSIS OF THE ALMS, AURA-LV AND AURORA 1 STUDIES
Authors: A. Askanase, K. C. Kalunian, M. Dall’era, N. Solomons, L. Hodge, M. Truman, E. Yap
Journal: Annals of the Rheumatic Diseases (2024)
AB0450 DIFFERENT PHENOTYPES AND UNMET TREATMENT NEEDS IN WOMEN WITH PSORIATIC ARTHRITIS: A CROSS-SECTIONAL STUDY
Authors: I. Hmamouchi, I. El Abbadi, N. Abbas, L. El Kibbi, A. Maroof, B. Elzorkany, N. A. Al-Ani, A. Ridha Adnan, N. Ihsan Awadh, F. I. Gorial, N. Al Chama, C. Haouichet, F. Alnaimat, S. Hannawi, S. Atawina, H. Halabi, M. Mashaleh, L. Aljazwi, A. Abogamal, L. Ayoub, E. Bouajina, R. Bahiri, S. Saad, M. Sabkar, K. Aouad, L. Gossec, N. Ziade
Journal: Annals of the Rheumatic Diseases (2024)
OP0048 CUTANEOUS LUPUS ERYTHEMATOSUS DISEASE AREA AND SEVERITY INDEX (CLASI) ACHIEVEMENT AND SUSTAINED RESPONSE WITH DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 INHIBITOR, IN A PHASE 2 TRIAL IN SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: C. Arriens, R. F. Van Vollenhoven, A. B. Gottlieb, C. Hobar, S. Pomponi, R. Koti, T. Wegman, V. P. Werth
Journal: Annals of the Rheumatic Diseases (2024)
AB0501 EFFECTIVENESS OF BARICITINIB VS OTHER TS/bDMARDs IN ACHIEVING EARLY LDA/REMISSION UP TO 2-YEARS: THE RA-BE-REAL STUDY IN EUROPEAN PATIENTS
Authors: R. Alten, A. Östör, C. J. Edwards, J. S. Smolen, E. Haladyj, K. J. Ng, S. Ogwu, Y. Kaneko, L. E. Kristensen
Journal: Annals of the Rheumatic Diseases (2024)
POS1316 THE IMPACT OF MENTAL HEALTH COMORBIDITIES ON QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A COVAD-2 STUDY
Authors: M. R. Pellico, M. Fornaro, V. Venerito, J. Day, A. Makol, P. Sen, E. Kadam, T. Chatterjee, P. Yaadav, S. Saha, T. Velikova, P. A. Goo, M. Milchert, Y. M. Chen, R. Shumnalieva, R. F. Caporali, I. Parodis, E. Nikiphorou, C. Wincup, S. Katsuyuki Shinjo, A. Nune, J. B. Lilleker, A. L. Tan, B. Vaidya, D. Dzifa, L. El Kibbi, N. Ziade, A. E. Gracia-Ramos, S. S. Shaharir, M. Kuwana, J. Knitza, C. Vinicio Caballero, M. A. Saavedra, L. Cavagna, O. Distler, A. T. M. T. Hasan, C. E. Toro-Gutierrez, H. Chinoy, V. Agarwal, R. Aggarwal, L. Gupta
Journal: Annals of the Rheumatic Diseases (2024)
POS0616 SHORTER LIFETIME OESTROGEN EXPOSURE INCREASES THE RISK OF RHEUMATOID ARTHRITIS IN PATIENTS WITH CLINICALLY SUSPECT ARTHRALGIA
Authors: J. W. Heutz, A. M. P. Boeren, S. Claassen, E. Van Mulligen, P. H. P. De Jong, A. H. M. Van der Helm – Van Mil
Journal: Annals of the Rheumatic Diseases (2024)
AB0454 LIPID ALTERATIONS AND THE IMPACT OF BIOLOGICS IN PSORIATIC ARTHRITIS MANAGEMENT
Authors: A. L. Guajardo-Aldaco, M. F. Elizondo-Benitez, D. A. Galarza-Delgado, I. J. Colunga-Pedraza, J. R. Azpiri-Lopez, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, V. González-González
Journal: Annals of the Rheumatic Diseases (2024)
AB0339 SERUM CONCENTRATIONS OF TYPE II COLLAGEN BIOMARKERS (CIIC, PIICP) DIFFER ACCORDING TO CHOLESTEROL LEVELS IN PATIENTS WITH EARLY OR MODERATE OSTEOARTHRITIS AND AFTER KNEE ARTHROPLASTY SURGERY
Authors: B. Thauerer, A. Odrovicsné-Tóth, M. Mustak-Blagusz, A. Salzer, B. Steinecker-Frohnwieser
Journal: Annals of the Rheumatic Diseases (2024)
OP0067 CATEGORIZATION OF SMALL INTESTINAL INVOLVEMENT IN SYSTEMIC SCLEROSIS USING HIGH-RESOLUTION JEJUNAL MANOMETRY
Authors: L. G. Alcala-Gonzalez, A. Guillen-Del-Castillo, A. Marin, A. Palacios Avila, C. Malagelada, C. P. Simeón-Aznar
Journal: Annals of the Rheumatic Diseases (2024)
POS1285 CAPILLAROSCOPIC FEATURES ACCORDING TO MYOSITIS SPESIFIC ANTIBODIES AND CLINICAL SUBGROUPS IN PATIENTS WITH INFLAMMATORY MYOSITIS
Authors: S. Sari, N. Aliyeva, B. Artim-Esen, A. Gül, M. Inanc, Y. Yalçinkaya
Journal: Annals of the Rheumatic Diseases (2024)
POS1177 TREATMENT WITH LORECIVIVINT LEADS TO IMPROVED LONG-TERM PATIENT ACCEPTABLE SYMPTOM STATE (PASS) COMPARED TO PLACEBO: DATA FROM PHASE 3 EXTENSION TRIAL
Authors: C. Swearingen, Y. Yazici, J. R. S. Tambiah, P. G. Conaghan
Journal: Annals of the Rheumatic Diseases (2024)
AB0306 IS THERE AN ASSOCIATION BETWEEN BONE MINERAL DENSITY AND ORAL HYGIENE IN RHEUMATOID ARTHRITIS PATIENTS?
Authors: S. Loukil, Y. Makhlouf, S. Miladi, A. Fazaa, H. Boussaa, L. Souabni, K. Ouennich, S. Kassab, S. Chekili, K. Benabdelghani, A. Laatar
Journal: Annals of the Rheumatic Diseases (2024)
OP0183 PREDICTORS OF SECUKINUMAB TREATMENT RESPONSE AND CONTINUATION IN AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE EUROSPA RESEARCH COLLABORATION NETWORK
Authors: M. Pons, S. Georgiadis, M. Østergaard, Z. Faizy Ahmadzay, S. Horskjær Rasmussen, S. Nysom Christiansen, K. Perdan Pirkmajer, Z. Rotar, D. DI Giuseppe, J. K. Wallman, B. Gudbjornsson, Ó. Pálsson, F. Iannone, B. Glintborg, A. G. Loft, K. Pavelka, J. Zavada, M. J. Nissen, A. Ciurea, H. Santos, M. H. Fernandes Lourenco, B. Michelsen, P. Mielnik, I. Castrejon, L. Kuusalo, V. Rantalaiho, G. J. Macfarlane, K. Laas, I. Van der Horst-Bruinsma, M. Van de Sande, C. Codreanu, C. Mogosan, İ. Sari, M. Lund Hetland, L. Midtbøll Ørnbjerg
Journal: Annals of the Rheumatic Diseases (2024)
OP0099 LUPUS LOW DISEASE ACTIVITY STATE (LLDAS) ACHIEVEMENT WITH DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 INHIBITOR, IN A PHASE 2 TRIAL IN SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: E. Morand, C. Hobar, S. Pomponi, R. Koti, T. Wegman, R. F. Van Vollenhoven
Journal: Annals of the Rheumatic Diseases (2024)
POS0581 EFFECT OF COMBINING A PATIENT DECISION AID WITH MOTIVATIONAL INTERVIEWING ON ADHERENCE AND THE SHARED DECISION MAKING QUALITY AMONG PATIENTS WITH A RECENT FRACTURE VISITING FRACTURE LIAISON SERVICE AND REQUIRING ANTI-OSTEOPOROSIS TREATMENTS – A QUASI-EXPERIMENTAL INTERVENTION STUDY
Authors: L. Maas, M. Hiligsmann, C. Wyers, S. Bours, T. Van der Weijden, J. Van den Bergh, M. Van Oostwaard, S. Van Kuijk, A. Boonen
Journal: Annals of the Rheumatic Diseases (2024)
POS0610 SIMILAR EFFICACY, SAFETY, AND IMMUNOGENICITY OF TOCILIZUMAB BIOSIMILAR (CT-P47) AND REFERENCE TOCILIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS: WEEK 32 RESULTS FROM THE PHASE III SINGLE TRANSITION STUDY
Authors: J. S. Smolen, J. Trefler, A. Racewicz, J. Jaworski, A. Zielinska, M. Krogulec, S. Jeka, R. Wojciechowski, K. Kolossa, A. Dudek, M. Krajewska-Włodarczyk, P. Hrycaj, P. A. Klimiuk, G. R. Burmester, S. H. Kim, Y. Bae, D. Jeon, G. Yang, Y. Jung, J. Hong, E. Keystone
Journal: Annals of the Rheumatic Diseases (2024)
POS0615 IS DMARD-FREE REMISSION IMPOSSIBLE FOR ALL RHEUMATOID ARTHRITIS PATIENTS OR ONLY FOR THOSE REQUIRING BIOLOGICALS?
Authors: J. W. Heutz, P. H. P. De Jong, M. Verstappen, A. H. M. Van der Helm – Van Mil, E. Van Mulligen
Journal: Annals of the Rheumatic Diseases (2024)
AB0423 PREVALENCE AND PREDICTIVE FACTORS OF PHYSICAL ACTIVITY AVOIDANCE IN PATIENTS WITH PSORIATIC ARTHRITIS
Authors: M. Minerba, D. Currado, A. Marino, O. Berardicurti, F. Saracino, L. Kun, E. Corberi, F. Trunfio, C. Salvolini, L. Lamberti, G. Lanaia, L. Quarta, A. Orlando, M. Vomero, P. Bearzi, L. Navarini, R. Giacomelli
Journal: Annals of the Rheumatic Diseases (2024)
POS0986 COMPARISON OF GUT MICROBIOTA BETWEEN PATIENTS WITH PSORIATIC ARTHRITIS AND OBESITY AND MATCHED CONTROLS, BEFORE AND AFTER A WEIGHT LOSS INTERVENTION
Authors: E. Klingberg, M. Leu Agelii, B. Eliasson, H. Forsblad-D’elia, A. Bilberg, I. Larsson, I. Gjertsson
Journal: Annals of the Rheumatic Diseases (2024)
POS1074 MORE THAN 40% OF ROUTINE CARE OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS PATIENTS SCREEN POSITIVE FOR ANXIETY, DEPRESSION AND/OR FIBROMYALGIA ON VALIDATED MDHAQ INDICES
Authors: J. Schmukler, A. M. Malfait, J. Block, T. Pincus
Journal: Annals of the Rheumatic Diseases (2024)
AB0424 REAL-LIFE EXPERIENCE OF UPADACITINIB IN PSORIATIC ARTHRITIS: RESULTS FROM A LARGE, NATIONWIDE, MULTICENTRIC COHORT
Authors: G. Lopalco, E. Celletti, M. Morrone, F. Atzeni, E. Bruschi, A. Carletto, A. Cauli, M. Cazzato, M. S. Chimenti, F. Ciccia, F. Cipollone, F. Conti, A. Corrado, F. Cozzini, L. Dagna, R. Foti, S. Gentileschi, E. Gremese, R. Gorla, G. Guggino, A. Lo Gullo, M. M. Luchetti, C. Montecucco, R. Ramonda, A. Semeraro, F. Salaffi, C. Salvarani, C. Selmi, E. Praino, R. F. Caporali, F. Iannone
Journal: Annals of the Rheumatic Diseases (2024)
POS1275 NASOPHARYNGEAL CARCINOMA AMONG PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES – DATA FROM A MULTICENTRE LONGITUDINAL COHORT IN HONG KONG
Authors: I. Y. K. Tang, H. So, C. W. S. Chan, T. H. Luk, B. T. L. Lai, R. Ho, M. L. Lee, V. H. S. Tang, D. Chan
Journal: Annals of the Rheumatic Diseases (2024)
POS1219 AN IL-17A SECRETING HLA-DR-CCR6+ T REGULATORY SUBPOPULATION SUPPRESSES T CELLS AND INDUCES INFLAMMATORY MEDIATORS IN SYNOVIAL FIBROBLAST
Authors: B. Van Heeswijk, M. Bongenaar, N. Davelaar, P. H. P. De Jong, R. J. E. M. Dolhain, H. Den Braanker, E. Lubberts
Journal: Annals of the Rheumatic Diseases (2024)
Autolougous platelet concentrates in esthetic medicine
Authors: Catherine Davies, Richard J. Miron
Journal: Periodontology 2000 (2024)

Abstract This narrative review summarizes current knowledge on the use of autologous platelet concentrates (APCs) in esthetic medicine, with the goal of providing clinicians with reliable information for clinical practice. APCs contain platelets that release various growth factors with potential applications in facial and dermatologic treatments. This review examines several facial esthetic applications of APCs, including acne scarring, skin rejuvenation, melasma, vitiligo, stretchmarks, peri‐orbital rejuvenation, peri‐oral rejuvenation, hair regeneration and the volumizing effects of APC gels. A systematic review of literature databases (PubMed/MEDLINE) was conducted up to October 2023 to identify randomized controlled trials (RCTs) in the English language on APCs for facial rejuvenation and dermatology. A total of 96 articles were selected including those on platelet rich plasma (PRP), plasma‐rich in growth factors (PRGF), and platelet‐rich fibrin (PRF). Clinical recommendations gained from the reviews are provided. In summary, the use of APCs in facial esthetics is a promising yet relatively recent treatment approach. Overall, the majority of studies have focused on the use of PRP with positive outcomes. Only few studies have compared PRP versus PRF with all demonstrating superior outcomes using PRF. The existing studies have limitations including small sample sizes and lack of standardized assessment criteria. Future research should utilize well‐designed RCTs, incorporating appropriate controls, such as split‐face comparisons, and standardized protocols for APC usage, including optimal number of sessions, interval between sessions, and objective improvement scores. Nevertheless, the most recent formulations of platelet concentrates offer clinicians an ability to improve various clinical parameters and esthetic concerns.
OP0184 A TREATMENT STRATEGY COMBINING TNF-INHIBITOR, METHOTREXATE AND STEROIDS IS NOT SUPERIOR TO METHOTREXATE AND STEROIDS IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM THE GOLMEPSA RANDOMISED, DOUBLE-BLIND CLINICAL TRIAL
Authors: G. De Marco, E. Hensor, P. S. Helliwell, S. Sultan, S. R. Dubash, X. Michelena, L. C. Coates, A. L. Tan, P. Emery, D. Mcgonagle, H. Marzo-Ortega
Journal: Annals of the Rheumatic Diseases (2024)